Oluwole Solomon Oladeji1,2, Abimbola Peter Oluyori1,2, Adewumi Oluwasogo Dada1,3. 1. Industrial Chemistry Unit, Department of Physical Sciences, Landmark University, P.M.B. 1001, Omu-Aran, Nigeria. 2. Landmark University SDG III: Good Health and Well-Being, Landmark University, P.M.B. 1001, Omu-Aran, Nigeria. 3. Landmark University SDG VI: Clean Water and Sanitation, Landmark University, P.M.B. 1001, Omu-Aran, Nigeria.
Abstract
Ethnopharmacology relevance: Morinda lucida is an ethnopharmacologically important plant that has traditionally been used to treat malaria in the Southwest of Nigeria. The aim of this study is to look into the antiplasmodial properties of different solvent extracts of Morinda lucida bark and leaves. Materials and methods: The antiplasmodial model, (or curative assay), was tested against Plasmodium berghei NK65, a chloroquine-sensitive Plasmodium berghei strain. In experimental mice, parasitaemia, percentage inhibition, weight changes, and packed cell volume were measured and compared to chloroquine (10 mg kg-1). Standard phytochemical procedures were used to evaluate the extracts' chemo-profile. Results and Discussion: Phytochemical analysis of the extracts revealed the presence of tannins, alkaloids, steroids, saponins, phenols, and alkaloids, among other metabolites. The highest quantities of total phenolic, total tannins, and total flavonoid content were found in 50% ethanolic extracts. There was significant decrease in the body weight of the mice after inoculation, however, after administration of crude extracts, an increase in weight was observed. A negative variation (-3.00 g) was observed in group without treatment. The ethanolic crude extracts (200 and 400 mg/kg) significantly increased the packed cell volume compared to other extracts. CQ treated experimental mice showed 100% inhibition with activity greater than extracts treated groups. The lowest inhibitory effect was observed in 200 mg/kg ethanolic bark extract treated group with activity of 72.16%. The antiplasmodial activities exhibited by these extracts could be linked to the chemical constituents investigated. Conclusion: The findings of this study suggest the use of M. lucida leaves and bark as a medicinal agent for malaria treatment and as a potential source of effective antimalarial templates. Further research is needed to determine the safety and toxicological profile of these extracts in vivo.
Ethnopharmacology relevance: Morinda lucida is an ethnopharmacologically important plant that has traditionally been used to treat malaria in the Southwest of Nigeria. The aim of this study is to look into the antiplasmodial properties of different solvent extracts of Morinda lucida bark and leaves. Materials and methods: The antiplasmodial model, (or curative assay), was tested against Plasmodium berghei NK65, a chloroquine-sensitive Plasmodium berghei strain. In experimental mice, parasitaemia, percentage inhibition, weight changes, and packed cell volume were measured and compared to chloroquine (10 mg kg-1). Standard phytochemical procedures were used to evaluate the extracts' chemo-profile. Results and Discussion: Phytochemical analysis of the extracts revealed the presence of tannins, alkaloids, steroids, saponins, phenols, and alkaloids, among other metabolites. The highest quantities of total phenolic, total tannins, and total flavonoid content were found in 50% ethanolic extracts. There was significant decrease in the body weight of the mice after inoculation, however, after administration of crude extracts, an increase in weight was observed. A negative variation (-3.00 g) was observed in group without treatment. The ethanolic crude extracts (200 and 400 mg/kg) significantly increased the packed cell volume compared to other extracts. CQ treated experimental mice showed 100% inhibition with activity greater than extracts treated groups. The lowest inhibitory effect was observed in 200 mg/kg ethanolic bark extract treated group with activity of 72.16%. The antiplasmodial activities exhibited by these extracts could be linked to the chemical constituents investigated. Conclusion: The findings of this study suggest the use of M. lucida leaves and bark as a medicinal agent for malaria treatment and as a potential source of effective antimalarial templates. Further research is needed to determine the safety and toxicological profile of these extracts in vivo.
Authors: Deepa Ganesh; Hans-Peter Fuehrer; Peter Starzengrüber; Paul Swoboda; Wasif Ali Khan; Johannes A B Reismann; Milena S K Mueller; Peter Chiba; Harald Noedl Journal: Parasitol Res Date: 2012-01-04 Impact factor: 2.289
Authors: Gabriel A Agbor; Philippe Moumbegna; Eunice O Oluwasola; Lynda U Nwosu; Rex-Clovis C Njoku; Shelly Kanu; Ephraim I Emekabasi; Femi Akin; Amarachi P Obasi; Florence A Abudei Journal: Afr J Tradit Complement Altern Med Date: 2011-06-01